The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Yoichi Mizutani

Department of Urology

Kyoto Prefectural University of Medicine

Kyoto

Japan

[email]@*.kpu-m.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan. 2001 - 2009

References

  1. Recent advances in molecular targeted therapy for metastatic renal cell carcinoma. Mizutani, Y. Int. J. Urol. (2009) [Pubmed]
  2. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis. Mizutani, Y., Nakanishi, H., Li, Y.N., Matsubara, H., Yamamoto, K., Sato, N., Shiraishi, T., Nakamura, T., Mikami, K., Okihara, K., Takaha, N., Ukimura, O., Kawauchi, A., Nonomura, N., Bonavida, B., Miki, T. Int. J. Oncol. (2007) [Pubmed]
  3. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance. Mizutani, Y., Nakanishi, H., Yamamoto, K., Li, Y.N., Matsubara, H., Mikami, K., Okihara, K., Kawauchi, A., Bonavida, B., Miki, T. J. Clin. Oncol. (2005) [Pubmed]
  4. Significance of orotate phosphoribosyltransferase activity in renal cell carcinoma. Mizutani, Y., Wada, H., Yoshida, O., Fukushima, M., Nakanishi, H., Miki, T. J. Urol. (2004) [Pubmed]
  5. Prognostic significance of orotate phosphoribosyltransferase activity in bladder carcinoma. Mizutani, Y., Wada, H., Fukushima, M., Yoshida, O., Nakanishi, H., Li, Y.N., Miki, T. Cancer (2004) [Pubmed]
  6. Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522. Mizutani, Y., Nakanishi, H., Li, Y.N., Sato, N., Kawauchi, A., Miki, T. J. Urol. (2004) [Pubmed]
  7. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma. Mizutani, Y., Matsubara, H., Yamamoto, K., Nan Li, Y., Mikami, K., Okihara, K., Kawauchi, A., Bonavida, B., Miki, T. Cancer (2004) [Pubmed]
  8. Significance of thymidylate synthase activity in renal cell carcinoma. Mizutani, Y., Wada, H., Yoshida, O., Fukushima, M., Nonomura, M., Nakao, M., Miki, T. Clin. Cancer Res. (2003) [Pubmed]
  9. Significance of dihydropyrimidine dehydrogenase activity in renal cell carcinoma. Mizutani, Y., Wada, H., Yoshida, O., Fukushima, M., Nakanishi, H., Nakao, M., Miki, T. Eur. J. Cancer (2003) [Pubmed]
  10. Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil. Mizutani, Y., Nakanishi, H., Yoshida, O., Fukushima, M., Bonavida, B., Miki, T. Eur. J. Cancer (2002) [Pubmed]
  11. Prognostic significance of a combination of thymidylate synthase and dihydropyrimidine dehydrogenase activities in grades 1 and 2 superficial bladder cancer. Mizutani, Y., Wada, H., Yoshida, O., Fukushima, M., Bonavida, B., Kawauchi, A., Miki, T. Oncol. Rep. (2002) [Pubmed]
  12. Cisplatin-induced in vivo differentiation of human embryonal carcinoma. Mizutani, Y., Sato, N., Kawauchi, A., Nonomura, N., Fukushima, M., Miki, T. BJU Int. (2002) [Pubmed]
  13. Prognostic significance of thymidine kinase activity in bladder carcinoma. Mizutani, Y., Wada, H., Yoshida, O., Fukushima, M., Kamoi, K., Miki, T. Cancer (2002) [Pubmed]
  14. The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer. Mizutani, Y., Wada, H., Fukushima, M., Yoshida, O., Ukimura, O., Kawauchi, A., Miki, T. Eur. J. Cancer (2001) [Pubmed]
  15. Significance of serum soluble Fas ligand in patients with bladder carcinoma. Mizutani, Y., Hongo, F., Sato, N., Ogawa, O., Yoshida, O., Miki, T. Cancer (2001) [Pubmed]
  16. Prognostic significance of thymidylate synthase activity in bladder carcinoma. Mizutani, Y., Wada, H., Ogawa, O., Yoshida, O., Fukushima, M., Nonomura, N., Miki, T. Cancer (2001) [Pubmed]
 
WikiGenes - Universities